Stéphane Bancel (Endpoints at JPM20)

Mod­er­na cal­i­brates fi­nal Covid-19 vac­cine ef­fi­ca­cy at 94.1% — and to­day it's gun­ning for the EUA

Near­ly a year ago, as the coro­n­avirus emerged in Chi­na, the NIH and four ma­jor com­pa­nies bet on an un­proven ge­net­ic tech­nol­o­gy as the best …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA